Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Allanore

Showing results (211-220 of 493) with videos related to

Pageof 50
Sort By:
Seminars in Arthritis and Rheumatism|May 3, 2016
Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international surveyCamelia Frantz, Jérôme Avouac, Oliver Distler, et al.
Rheumatology (Oxford, England)|January 18, 2021
Influence of inflammatory and non-inflammatory rheumatic disorders on the clinical and biological profile of type-2 diabetesJérôme Avouac, Muriel Elhai, Marine Forien, et al.
Arthritis and Rheumatism|July 20, 2011
Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cellsJérôme Avouac, Nicolas Cagnard, Jörg H Distler, et al.
Rheumatology (Oxford, England)|October 4, 2023
Should complete B cell depletion be maintained in patients treated long-term with rituximab for rheumatoid arthritis?Roba Ghossan, Omar Al Tabaa, Alice Combier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 23, 2023
Effects of B Cell Depletion by CD19-Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic SclerosisJérôme Avouac, Anne Cauvet, Cindy Orvain, et al.
Arthritis Research & Therapy|April 23, 2013
Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosisJérôme Avouac, Maeva Vallucci, Vanessa Smith, et al.
Journal of Scleroderma and Related Disorders|April 7, 2022
Quality of life in SSc-ILD patients: Understanding the impact of the ILD and the needs of the SSc-ILD patients and their need for caregivers in FranceYannick Allanore, Joel Constans, Dominique Godard, et al.
Seminars in Arthritis and Rheumatism|December 27, 2025
Hand function impairment in Systemic Sclerosis: determinants through investigations of clinical, radiographic and ultrasonographic featuresGiulia Franchi, Elena Marazzi, Alain Lescoat, et al.
Annals of the Rheumatic Diseases|March 11, 2016
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosisNadira Ruzehaji, Camelia Frantz, Matthieu Ponsoye, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Patient perception of disease burden in diffuse cutaneous systemic sclerosisDinesh Khanna, Yannick Allanore, Christopher P Denton, et al.
Pageof 50

Showing results (211-220 of 493) with videos related to

Sort By:
Pageof 50
Seminars in Arthritis and Rheumatism|May 3, 2016
Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international surveyCamelia Frantz, Jérôme Avouac, Oliver Distler, et al.
Rheumatology (Oxford, England)|January 18, 2021
Influence of inflammatory and non-inflammatory rheumatic disorders on the clinical and biological profile of type-2 diabetesJérôme Avouac, Muriel Elhai, Marine Forien, et al.
Arthritis and Rheumatism|July 20, 2011
Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cellsJérôme Avouac, Nicolas Cagnard, Jörg H Distler, et al.
Rheumatology (Oxford, England)|October 4, 2023
Should complete B cell depletion be maintained in patients treated long-term with rituximab for rheumatoid arthritis?Roba Ghossan, Omar Al Tabaa, Alice Combier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 23, 2023
Effects of B Cell Depletion by CD19-Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic SclerosisJérôme Avouac, Anne Cauvet, Cindy Orvain, et al.
Arthritis Research & Therapy|April 23, 2013
Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosisJérôme Avouac, Maeva Vallucci, Vanessa Smith, et al.
Journal of Scleroderma and Related Disorders|April 7, 2022
Quality of life in SSc-ILD patients: Understanding the impact of the ILD and the needs of the SSc-ILD patients and their need for caregivers in FranceYannick Allanore, Joel Constans, Dominique Godard, et al.
Seminars in Arthritis and Rheumatism|December 27, 2025
Hand function impairment in Systemic Sclerosis: determinants through investigations of clinical, radiographic and ultrasonographic featuresGiulia Franchi, Elena Marazzi, Alain Lescoat, et al.
Annals of the Rheumatic Diseases|March 11, 2016
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosisNadira Ruzehaji, Camelia Frantz, Matthieu Ponsoye, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Patient perception of disease burden in diffuse cutaneous systemic sclerosisDinesh Khanna, Yannick Allanore, Christopher P Denton, et al.
Pageof 50